Pharma stocks face volatility on US plan to reduce drug prices
As tariff fears ease elsewhere, the pharmaceutical sector now finds itself in the crosshairs thanks to an executive order trailed by president Donald Trump on 11 May. The administration apparently mandated a reduction in...
15 May 2025